Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 2Sarcoma 1Dermatologic 1

Conditions

Keratosis, Actinic 46Melanoma 27Skin Neoplasms 14Carcinoma, Basal Cell 9Lymphoma, T-Cell, Cutaneous 8Neoplasm Metastasis 5Mycosis Fungoides 5Lung Neoplasms 5Keratosis 5Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Carcinoma 3Breast Neoplasms 3Uveal Melanoma 2Skin Diseases 2Sezary Syndrome 2Prostatic Neoplasms 2Head and Neck Neoplasms 2Carcinoma, Squamous Cell 2Carcinoma, Renal Cell 2Brain Neoplasms 2Waldenstrom Macroglobulinemia 1Subcutaneous panniculitis-like T-cell lymphoma 1Squamous Cell Carcinoma of Head and Neck 1Skin Substitutes 1Seroma 1Renal Transplant Patients at High-risk for Skin Cancer 1Psoriasis 1Pituitary Neoplasms 1Pituitary ACTH Hypersecretion 1

Interventions

Etanercept 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Psoriasis × Dermatologic × Clear all
NCT01053819 2018-02-23

Can We Miss Pigmented Lesions in Psoriasis Patients?

University of Alabama at Birmingham

Phase 4 Completed
6 enrolled 3 charts
Dermatologic

Melanoma, Psoriasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡